Defensive companies have been out of favour for a long time but now a series of factors could push them back into the spotlight, writes Richard Jeffrey, chief investment officer, Cazenove Capital.
Defensive companies have been out of favour for so long, any attempt to suggest they may resurge is rightly met with some scepticism. The staid mega-caps in pharmaceuticals, tobacco and telecoms may have been cheap, but there were few catalysts for a change in market sentiment. However, there is a confluence of factors that should create momentum for a number of these unloved giants. Perhaps the first and most important point supporting a more defensive orientation to markets is that some of the notable success stories of the past few years are running out of steam. This is particularly ...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes